Roles played by lymphocyte function-associated antigen-1 in the regulation of lymphocytic cholinergic activity

Life Sciences

Volumn 80, Issue 24-25, 2007, Pages 2320-2324

  Fujii, Takeshi ^a,b   Takada Takatori, Yuki ^b   Kawashima, Koichiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b DOSHISHA WOMEN'S COLLEGE OF LIBERAL ARTS   (Japan)

Author keywords

Acetylcholine; Choline acetyltransferase; Lymphocyte function associated antigen 1; Muscarinic acetylcholine receptor; Nicotinic acetylcholine receptor; Simvastatin

Indexed keywords

ACETYLCHOLINE; BUCLADESINE; CD18 ANTIGEN; CD3 ANTIBODY; CELL SURFACE MARKER; CHOLESTEROL; CHOLINE ACETYLTRANSFERASE; CYCLIC AMP; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MONOCLONAL ANTIBODY; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PHORBOL ESTER; PHYTOHEMAGGLUTININ; PROTEIN KINASE C; SIMVASTATIN; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL SURFACE; CHOLINERGIC SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE MIGRATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; RECEPTORS, NICOTINIC; SIMVASTATIN; T-LYMPHOCYTES;

EID: 34249323707     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.012     Document Type: Article

References (26)

1. Alderson R.F., Hua Z.W., and Hersh L.B. Nerve growth factor and phorbol esters increase the number of choline acetyltransferase-positive cells in two morphologically distinct classes of basal forebrain neurons in primary cultures. Developmental Brain Research 48 2 (1989) 229-241
2. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. Journal of Neurochemistry 24 2 (1975) 407-409
3. 3 muscarinic acetylcholine receptors in human T- and B-cells. Japanese Journal of Pharmacology 84 (2000) 124-132
4. Fujii T., and Kawashima K. Activation of an independent, non-neuronal cholinergic system in T lymphocytes via three different pathways. Prog. No. 710.3. 2003 Abstract Viewer and Itinerary Planner (2003), Society for Neuroscience, New Orleans CD-ROM
5. Fujii T., Tsuchiya T., Yamada S., Fujimoto K., Suzuki T., Kasahara T., and Kawashima K. Localization and synthesis of acetylcholine in human leukemic T-cell lines. Journal of Neuroscience Research 44 1 (1996) 66-72
6. Fujii T., Yamada S., Watanabe Y., Misawa H., Tajima S., Fujimoto K., Kasahara T., and Kawashima K. Induction of choline acetyltransferase mRNA in human mononuclear leukocytes stimulated by phytohemagglutinin, a T-cell activator. Journal of Neuroimmunology 82 1 (1998) 101-107
7. Fujii T., Ushiyama N., Hosonuma K., Suenaga A., and Kawashima K. Effects of human antithymocyte Globulin on acetylcholine synthesis, its release and choline acetyltransferase transcription in a human leukemic T-cell line. Journal of Neuroimmunology 128 1-2 (2002) 1-8
8. 5 muscarinic acetylcholine receptor in human T- and B-lymphocytes during immunological responses. Neurochemical Research 28 3-4 (2003) 423-429
9. Fujii T., Masuyama K., and Kawashima K. Simvastatin regulates non-neuronal cholinergic activity in T lymphocytes via CD11a-mediated pathways. Journal of Neuroimmunology 179 1-2 (2006) 101-107
10. Horiuchi Y., Fujii T., Kamimura Y., and Kawashima K. The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity. Journal of Neuroimmunology 144 1-2 (2003) 46-52
11. Kawashima K., and Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacology and Therapeutics 86 1 (2000) 29-48
12. Kawashima K., and Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sciences 74 6 (2003) 675-696
13. Kawashima K., and Fujii T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Frontiers in Bioscience 9 9 (2004) 2063-2085
14. Kobashigawa J.A., Katznelson S., Laks H., Johnson J.A., Yeatman L., Wang X.M., Chia D., Terasaki P.I., Sabad A., Cogert G.A., Trosian K., Hamilton M.A., Moriguchi J.D., Kawata N., Hage A., Drinkwater D.C., and Stevenson L.W. Effect of pravastatin on outcomes after cardiac transplantation. New England Journal of Medicine 333 10 (1995) 621-627
15. Kurzen, H., Wessler, I., Kirkpatrick, C.J. Kawashima, K., Grando, S.A., in press. The Non-neuronal Cholinergic System of Human Skin. Hormone and Metabolic Research.
16. Ledbetter J.A., June C.H., Grosmaire L.S., and Rabinovitch P.S. Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 84 5 (1987) 1384-1388
17. Masuyama K., Fujii T., and Kawashima K. Phorbol 12-myristate 13-acetate increases choline acetyltransferase activity in human leukemic T cell line MOLT-3. Journal of Pharmacological Sciences 97 Suppl. I (2005) 230P
18. Misawa H., Takahashi R., and Deguchi T. Transcriptional regulation of choline acetyltransferase gene by cyclic AMP. Journal of Neurochemistry 60 4 (1993) 1383-1387
19. Neuhaus O., Stuve O., Zamvil S.S., and Hartung H.P. Are statins a treatment option for multiple sclerosis. Lancet Neurology 3 6 (2004) 369-371
20. Paldi-Haris P., Szelenyi J.G., Nguyen T.H., and Hollan S.R. Changes in the expression of the cholinergic structures of human T lymphocytes due to maturation and stimulation. Thymus 16 2 (1990) 119-122
21. Remberger M., Svahn B.M., Heutschke P., Lofgren C., and Ringden O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplantation 24 8 (1999) 823-830
22. Rinner I., Kawashima K., and Schauenstein K. Rat lymphocytes produce and secrete acetylcholine in dependence of differentiation and activation. Journal of Neuroimmunology 81 1-2 (1998) 31-37
23. 4 receptor agonist, in human leukemic T cells of the MOLT-3 line. Vascular Pharmacology 41 2 (2004) 51-58
24. Szelenyi J., Paldi-Haris P., and Hollan S. Changes in the cholinergic system of lymphocytes due to mitogenic stimulation. Immunology Letters 16 1 (1987) 49-54
25. Wanner C., Quaschning T., and Weingarnter K. Impact of dyslipidaemia in renal transplant recipients. Current Opinion in Urology 10 2 (2000) 77-80
26. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., and Hommel U. Statins selectivity inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nature Medicine 7 6 (2001) 687-692